Tag archive for ‘GE decides to manufacture Protin A’
Repligen: More Detailed Analysis on GE Decision to Manufacture Protein A
Overview GE Healthcare, announced plans to launch a new chromatography resin in the first half of 2018 which will not use Repligen as the manufacturer of the associated protein A ligand. This news led to a 14% decrease in stock price from $43.22 at the close on September 25 to a closing price of $36.98 […]